Pure Global

Abbott "Mayris" hepatitis C virus antibody test reagent (4th generation) - Taiwan Registration 292095ad9a4175e09cffbd2b83f91eeb

Access comprehensive regulatory information for Abbott "Mayris" hepatitis C virus antibody test reagent (4th generation) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 292095ad9a4175e09cffbd2b83f91eeb and manufactured by DiaSorin South Africa (Pty) Ltd.. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
292095ad9a4175e09cffbd2b83f91eeb
Registration Details
Taiwan FDA Registration: 292095ad9a4175e09cffbd2b83f91eeb
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Abbott "Mayris" hepatitis C virus antibody test reagent (4th generation)
TW: ไบžๅŸนโ€ๅฆ™่Šฎ็ตฒโ€Cๅž‹่‚็‚Ž็—…ๆฏ’ๆŠ—้ซ”ๆชข้ฉ—่ฉฆๅŠ‘(็ฌฌๅ››ไปฃ)
Risk Class 3
Cancelled

Registration Details

292095ad9a4175e09cffbd2b83f91eeb

DHA00601174100

Company Information

Product Details

Enzyme immunoassay is used to test human serum or plasma for antibodies to hepatitis C virus.

B Hematology, pathology, and genetics

import

Dates and Status

Aug 08, 2005

Aug 12, 2022

Apr 18, 2022

Cancellation Information

Logged out

่‡ช่ซ‹่จป้Šท